サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1795185

トロポニンの世界市場

Troponin

出版日
ページ情報
英文 290 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.53円
トロポニンの世界市場
出版日: 2025年08月21日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 290 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

トロポニンの世界市場は2030年までに15億米ドルに達する

2024年に12億米ドルと推定されるトロポニンの世界市場は、分析期間2024-2030年にCAGR 4.9%で成長し、2030年には15億米ドルに達すると予測されます。本レポートで分析しているセグメントの1つであるトロポニンIは、CAGR 3.8%を記録し、分析期間終了時には6億7,130万米ドルに達すると予測されています。トロポニンTセグメントの成長率は、分析期間中CAGR 6.4%と推定されます。

米国市場は3億1,530万米ドルと推定、中国はCAGR 7.6％で成長予測

米国のトロポニン市場は、2024年に3億1,530万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 7.6%で推移し、2030年には3億140万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.4％と4.8％と予測されています。欧州では、ドイツがCAGR 3.1%で成長すると予測されています。

世界のトロポニン市場- 主要動向と促進要因のまとめ

トロポニンが最新の心血管診断に欠かせない理由とは？

トロポニン、特にその心臓特異的形態（cTnIおよびcTnT）は、心筋梗塞診断の要です。心筋に障害が起こると、トロポニンは血液中に放出され、心筋梗塞の正確かつ早期の指標となります。胸痛患者に対する救急処置室での使用により、診断のスピードと精度が劇的に向上しました。

心臓発作以外にも、心不全、腎臓病、さらにはCOVID-19のような心臓ストレスが存在する感染症においても、トロポニンレベルの上昇が研究されています。その診断範囲の拡大により、トロポニンはシングルユースのマーカーからマルチコンディションのモニタリングツールへと変貌しつつあります。このような有用性の高まりが、迅速な検査やリアルタイムの臨床判断のためのポータブルデバイスの技術革新に拍車をかけています。

テクノロジーと臨床プロトコールはトロポニン検査の採用にどのような影響を与えていますか？

高感度トロポニンアッセイが標準になりつつあり、超低濃度での検出が可能になっています。これにより、不必要な入院を減らし、救急医療を合理化する早期のルールイン/ルールアウト・プロトコルが可能になりました。診断機器メーカーは、トロポニンと他のバイオマーカーを組み合わせたマルチプレックスアナライザーを開発し、包括的な心臓プロファイリングを行っています。

臨床プロトコールでは、トロポニン検査が、エビデンスに基づくガイドラインに支えられた、より広範なリスクアルゴリズムに組み込まれています。クラウド接続とAIによる解釈を備えたポータブル検査機器は、十分なサービスを受けていない遠隔地へのアクセスを拡大しています。規制の調整と保険償還も、世界中の病院や診療所での普及を促進しています。

トロポニン市場の成長はいくつかの要因によって牽引される...

トロポニン市場の成長は、心血管疾患罹患率の増加、高感度アッセイの普及、リスクベースの臨床アルゴリズムへの統合など、いくつかの要因によって牽引されています。迅速で正確な緊急診断へのニーズが、次世代免疫測定プラットフォームへの投資を促進しています。在宅検査システムや分散型検査システムの拡大により、新たな販売チャネルが開拓されつつあります。臨床ガイドラインでは、ハイリスク集団に対するルーチンのトロポニン検査がますます推奨されるようになっており、急性期医療と慢性期医療の両方の場面で一貫した需要を牽引しています。

セグメント

タイプ（トロポニンI、トロポニンT、トロポニンComplex、その他のトロポニンタイプ）;アプリケーション（心筋梗塞アプリケーション、急性冠症候群アプリケーション、うっ血性心不全アプリケーション、心筋症アプリケーション、その他のアプリケーション）

調査対象企業の例

  • Abbott Laboratories
  • Abcam plc
  • Bio-Rad Laboratories, Inc.
  • Biomerica, Inc.
  • Biomerieux SA
  • Boditech Med Inc.
  • Danaher Corporation（Beckman Coulter）
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche AG
  • Fujirebio Inc.（H.U. Group）
  • HyTest Ltd.
  • LumiraDx Limited
  • Merck KGaA
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP38259

Global Troponin Market to Reach US$1.5 Billion by 2030

The global market for Troponin estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Troponin I, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$671.3 Million by the end of the analysis period. Growth in the Troponin T segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$315.3 Million While China is Forecast to Grow at 7.6% CAGR

The Troponin market in the U.S. is estimated at US$315.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$301.4 Million by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Troponin Market - Key Trends & Drivers Summarized

Why Is Troponin Central to Modern Cardiovascular Diagnostics?

Troponin, particularly its cardiac-specific forms (cTnI and cTnT), is a cornerstone of myocardial infarction diagnosis. When heart muscle damage occurs, troponin is released into the bloodstream, making it a precise and early indicator of cardiac events. Its use in emergency rooms for patients with chest pain has dramatically improved diagnostic speed and accuracy.

Beyond heart attacks, elevated troponin levels are being studied in heart failure, kidney disease, and even infections like COVID-19, where cardiac stress is present. Its expanding diagnostic scope is transforming troponin from a single-use marker into a multi-condition monitoring tool. This growing utility is fueling innovation in rapid testing and portable devices for real-time clinical decision-making.

How Are Technology and Clinical Protocols Influencing Troponin Testing Adoption?

High-sensitivity troponin assays are becoming the standard, enabling detection at ultra-low concentrations. This has enabled early rule-in/rule-out protocols that reduce unnecessary admissions and streamline emergency care. Diagnostic manufacturers are developing multiplex analyzers that combine troponin with other biomarkers for comprehensive cardiac profiling.

Clinical protocols now incorporate troponin testing into broader risk algorithms, supported by evidence-based guidelines. Portable testing devices with cloud connectivity and AI-driven interpretation are extending access to underserved and remote areas. Regulatory alignment and insurance reimbursement are also facilitating widespread adoption in hospitals and clinics worldwide.

The Growth in the Troponin Market Is Driven by Several Factors…

The growth in the troponin market is driven by several factors including increasing cardiovascular disease incidence, widespread deployment of high-sensitivity assays, and integration into risk-based clinical algorithms. The need for fast, accurate emergency diagnostics has driven investment in next-gen immunoassay platforms. The expansion of home-based and decentralized testing systems is opening up new distribution channels. Clinical guidelines are increasingly recommending routine troponin testing for high-risk populations, driving consistent demand in both acute and chronic care settings.

SCOPE OF STUDY:

The report analyzes the Troponin market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Troponin I, Troponin T, Troponin Complex, Other Troponin Types); Application (Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Abcam plc
  • Bio-Rad Laboratories, Inc.
  • Biomerica, Inc.
  • Biomerieux SA
  • Boditech Med Inc.
  • Danaher Corporation (Beckman Coulter)
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche AG
  • Fujirebio Inc. (H.U. Group)
  • HyTest Ltd.
  • LumiraDx Limited
  • Merck KGaA
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Troponin - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular Events Propels Adoption of High-Sensitivity Troponin Assays
    • Integration of Troponin Testing in Emergency Protocols Strengthens Clinical Relevance Across Care Settings
    • Technological Advancements in Point-of-Care Diagnostics Expand Access to Troponin Testing
    • Shift Toward Multi-Marker Panels Throws the Spotlight on Troponin as a Central Biomarker
    • Increasing Investment in Decentralized Healthcare Drives Demand for Portable Testing Platforms
    • AI and Predictive Analytics Tools Enhance Interpretation and Stratification of Troponin Results
    • Widening Use of Troponin in Chronic Disease Monitoring Expands Diagnostic Applications
    • Regulatory Support for Early Detection Programs Sustains Market Momentum
    • Growing Hospital Accreditation Requirements Spur Standardization of Troponin Testing Protocols
    • Expansion of Telehealth and Remote Monitoring Enhances Relevance of Digital Troponin Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Troponin Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Troponin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Troponin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Troponin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Troponin I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Troponin I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Troponin I by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Troponin T by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Troponin T by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Troponin T by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Troponin Complex by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Troponin Complex by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Troponin Complex by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Troponin Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Troponin Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Troponin Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Myocardial Infarction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Myocardial Infarction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Myocardial Infarction Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Acute Coronary Syndrome Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Acute Coronary Syndrome Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Acute Coronary Syndrome Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Congestive Heart Failure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Congestive Heart Failure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Congestive Heart Failure Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiomyopathy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiomyopathy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Cardiomyopathy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • JAPAN
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • CHINA
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: China 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • EUROPE
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Troponin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Troponin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Troponin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • FRANCE
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: France 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • GERMANY
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Troponin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Troponin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Troponin by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • INDIA
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: India 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Troponin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Troponin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Troponin by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Troponin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Troponin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Troponin by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • AFRICA
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION